메뉴 건너뛰기
Ophthalmologe
Volumn 107, Issue 9, 2010, Pages 827-830
Effect of intravitreal bevacizumab on pigment epithelial detachment in occult choroidal neovascularization;Effekt von Bevacizumab auf die Abhebung des retinalen Pigmentepithels bei okkulter choroidaler Neovaskularisation
Author keywords

Bevacizumab; Epithelial detachment; Intravitreal injection; Neovascular AMD; Occult CNV
Indexed keywords

EID: 77956955246     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-010-2166-z     Document Type: Article
Times cited : (5)
References (18)
  • 1
    • 0020075129 scopus 로고
    • Retinal pigment epithelial detachments in the elderly: a controlled trial of argon laser photocoagulation
    • The Moorfields Macular Study Group
    • The Moorfields Macular Study Group (1982) Retinal pigment epithelial detachments in the elderly: a controlled trial of argon laser photocoagulation. Br J Ophthalmol 66: 1-16.
    • (1982) Br J Ophthalmol , vol.66 , pp. 1-16
  • 2
    • 48449085770 scopus 로고    scopus 로고
    • A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations
    • Algvere PV, Steen B, Seregard S, Kvanta A (2008) A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations. Acta Ophthalmol 86: 482-489.
    • (2008) Acta Ophthalmol , vol.86 , pp. 482-489
    • Algvere, P.V.1    Steen, B.2    Seregard, S.3    Kvanta, A.4
  • 3
    • 0021844870 scopus 로고
    • Retinal pigment epithelial detachments in the elderly: classification and outcome
    • Casswell AG, Kohen D, Bird AC (1985) Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 69: 397-403.
    • (1985) Br J Ophthalmol , vol.69 , pp. 397-403
    • Casswell, A.G.1    Kohen, D.2    Bird, A.C.3
  • 4
    • 34250210397 scopus 로고    scopus 로고
    • RPE tears after pegaptanib treatment in age-related macular degeneration
    • Chang LK, Flaxel CJ, Lauer AK, Sarraf D (2007) RPE tears after pegaptanib treatment in age-related macular degeneration. Retina 27: 857-863.
    • (2007) Retina , vol.27 , pp. 857-863
    • Chang, L.K.1    Flaxel, C.J.2    Lauer, A.K.3    Sarraf, D.4
  • 5
    • 33847196122 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study
    • Chen CY, Wong TY, Heriot WJ (2007) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study. Am J Ophthalmol 143: 510-512.
    • (2007) Am J Ophthalmol , vol.143 , pp. 510-512
    • Chen, C.Y.1    Wong, T.Y.2    Heriot, W.J.3
  • 6
    • 33750575485 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study
    • Costa RA, Jorge R, Calucci D et al (2006) Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study. Invest Ophthalmol Vis Sci 47: 4569-4578.
    • (2006) Invest Ophthalmol Vis Sci , vol.47 , pp. 4569-4578
    • Costa, R.A.1    Jorge, R.2    Calucci, D.3
  • 7
    • 47849096396 scopus 로고    scopus 로고
    • Intravitreal administration of triamcinolone and bevacizumab for pigment epithelial detachment in conjunction with AMD
    • Frimpong-Boateng A, Varde MA, Rufer F et al (2008) Intravitreal administration of triamcinolone and bevacizumab for pigment epithelial detachment in conjunction with AMD. Ophthalmologe 105: 661-668.
    • (2008) Ophthalmologe , vol.105 , pp. 661-668
    • Frimpong-Boateng, A.1    Varde, M.A.2    Rufer, F.3
  • 8
    • 33750296920 scopus 로고    scopus 로고
    • The international intravitreal bevacizumab safety survey: using the internet to assess drug safety worldwide
    • Fung AE, Rosenfeld PJ, Reichel E (2006) The international intravitreal bevacizumab safety survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90: 1344-1349.
    • (2006) Br J Ophthalmol , vol.90 , pp. 1344-1349
    • Fung, A.E.1    Rosenfeld, P.J.2    Reichel, E.3
  • 9
    • 67649949020 scopus 로고    scopus 로고
    • Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration
    • Kashani AH, Keane PA, Dustin L et al (2009) Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci 50: 3366-3373.
    • (2009) Invest Ophthalmol Vis Sci , vol.50 , pp. 3366-3373
    • Kashani, A.H.1    Keane, P.A.2    Dustin, L.3
  • 10
    • 33746276707 scopus 로고    scopus 로고
    • Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration
    • Meyer CH, Mennel S, Schmidt JC, Kroll P (2006) Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration. Br J Ophthalmol 90: 1207-1208.
    • (2006) Br J Ophthalmol , vol.90 , pp. 1207-1208
    • Meyer, C.H.1    Mennel, S.2    Schmidt, J.C.3    Kroll, P.4
  • 11
    • 0036951480 scopus 로고    scopus 로고
    • Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications
    • Pauleikhoff D, Loffert D, Spital G et al (2002) Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240: 533-538.
    • (2002) Graefes Arch Clin Exp Ophthalmol , vol.240 , pp. 533-538
    • Pauleikhoff, D.1    Loffert, D.2    Spital, G.3
  • 12
    • 77956968236 scopus 로고    scopus 로고
    • Pedersen KB, Sjolie AK, Moller F (2008) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patients. Acta Ophthalmol.
  • 13
    • 33745782355 scopus 로고    scopus 로고
    • Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
    • Rich RM, Rosenfeld PJ, Puliafito CA et al (2006) Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 26: 495-511.
    • (2006) Retina , vol.26 , pp. 495-511
    • Rich, R.M.1    Rosenfeld, P.J.2    Puliafito, C.A.3
  • 14
    • 33745385689 scopus 로고    scopus 로고
    • Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration
    • Singh RP, Sears JE (2006) Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 142: 160-162.
    • (2006) Am J Ophthalmol , vol.142 , pp. 160-162
    • Singh, R.P.1    Sears, J.E.2
  • 15
    • 33745091547 scopus 로고    scopus 로고
    • Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
    • Spaide RF, Laud K, Fine HF et al (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26: 383-390.
    • (2006) Retina , vol.26 , pp. 383-390
    • Spaide, R.F.1    Laud, K.2    Fine, H.F.3
  • 16
    • 36448993366 scopus 로고    scopus 로고
    • Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES)
    • Wu L, Martinez-Castellanos MA, Quiroz-Mercado H et al (2008) Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 246: 81-87.
    • (2008) Graefes Arch Clin Exp Ophthalmol , vol.246 , pp. 81-87
    • Wu, L.1    Martinez-Castellanos, M.A.2    Quiroz-Mercado, H.3
  • 17
    • 33845750072 scopus 로고    scopus 로고
    • Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration
    • Yoganathan P, Deramo VA, Lai JC et al (2006) Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration. Retina 26: 994-998.
    • (2006) Retina , vol.26 , pp. 994-998
    • Yoganathan, P.1    Deramo, V.A.2    Lai, J.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.